feed,title,long_url,short_url
Benzinga,Deutsche Bank Cuts FedEx's Price Target By 4%,https://benzinga.com/analyst-ratings/analyst-color/22/03/26224397/deutsche-bank-cuts-fedexs-price-target-by-4,https://bit.ly/3wlRFxl
Benzinga,"Pulmatrix's COPD Candidate Shows Early Safety, Preliminary Pharmacokinetic Results",https://benzinga.com/general/biotech/22/03/26223549/pulmatrixs-copd-candidate-shows-early-safety-preliminary-pharmacokinetic-results,https://bit.ly/3udJyAk
Benzinga,"Pear Therapeutics, SoftBank Team On Sleep/Wake Disorder Therapeutic For Japanese Market",https://benzinga.com/news/22/03/26222854/pear-therapeutics-softbank-team-on-sleepwake-disorder-therapeutic-for-japanese-market,https://bit.ly/3CWhB45
Benzinga,NeuroSense Shares Surge Over 400% As FDA Clears Initiating Pharmacokinetic Study Of PrimeC,https://benzinga.com/general/biotech/22/03/26222015/neurosense-shares-surge-over-400-as-fda-clears-initiating-pharmacokinetic-study-of-primec,https://bit.ly/3N4N9JE
